PILL Short Volume

Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $27.0M, listed on AMEX, carrying a beta of 2.23 to the broader market. The Direxion Daily Pharmaceutical & Medical Bull 3X ETF seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. public since 2017-11-15.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
34.5K
Total Volume
48.2K
Short %
71.53%
30-Day Avg Short %
47.37%

Showing 30 days of FINRA short volume data for Direxion Daily Pharmaceutical & Medical Bull 3X ETF.

Learn how short volume is reported and how to read the data →

Frequently asked PILL short volume questions

What is the daily PILL short volume?
As of May 15, 2026, Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) short volume is 34.5K shares against 48.2K total reported volume, or 71.53% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is PILL short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does PILL short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.